AKT1 and schizophrenia: Using the MK-801 mouse model of schizophrenia, Yu et al. [213] proposed that quetiapine may reduce oligodendrocyte apoptosis, promote oligodendrocyte-induced myelination through the modulation of PI3k/Akt signalling and thus reduce cognitive impairment in schizophrenia.